5.65
前日終値:
$5.41
開ける:
$5.31
24時間の取引高:
365.67K
Relative Volume:
0.68
時価総額:
$432.13M
収益:
$14.02M
当期純損益:
$-84.03M
株価収益率:
-3.8435
EPS:
-1.47
ネットキャッシュフロー:
$-125.54M
1週間 パフォーマンス:
+3.10%
1か月 パフォーマンス:
-25.26%
6か月 パフォーマンス:
-5.68%
1年 パフォーマンス:
+11.00%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
名前
Meiragtx Holdings Plc
セクター
電話
646-860-7985
住所
450 EAST 29TH STREET, NEW YORK, NY
MGTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MGTX
Meiragtx Holdings Plc
|
5.65 | 432.13M | 14.02M | -84.03M | -125.54M | -1.47 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-31 | 再開されました | Chardan Capital Markets | Buy |
2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
2020-09-15 | 再開されました | BofA Securities | Buy |
2019-09-03 | 開始されました | Piper Jaffray | Overweight |
2019-02-27 | 繰り返されました | Chardan Capital Markets | Buy |
2018-07-03 | 開始されました | Barclays | Overweight |
2018-07-03 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Meiragtx Holdings Plc (MGTX) 最新ニュース
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Corebridge Financial Inc. - Defense World
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 By Investing.com - Investing.com India
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 - Investing.com
(MGTX) Trading Advice - news.stocktradersdaily.com
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com Australia
MeiraGTx Holdings secures new lease, terminates old sublease By Investing.com - Investing.com Canada
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - MarketScreener
When the Price of (MGTX) Talks, People Listen - news.stocktradersdaily.com
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume – Here’s Why - Defense World
Top 10 AI News Updates Taking Wall Street By Storm - Insider Monkey
Plaudits For MeiraGTx And Its Parkinson’s AI Pact - insights.citeline.com
US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports
MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues - Simply Wall St
MGTX stock touches 52-week high of $7.9 amid market optimism - Investing.com
MeiraGTx Shares Soar After Joint Venture Deal With Hologen -March 13, 2025 at 03:31 pm EDT - Marketscreener.com
Top Midday Gainers -March 13, 2025 at 02:24 pm EDT - Marketscreener.com
MGTX’s price-to-sales ratio: A comparative analysis with its peers - US Post News
MeiraGTx Holdings plc SEC 10-K Report - TradingView
MeiraGTx earnings beat by $0.08, revenue topped estimates - Investing.com UK
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga India
MeiraGTx (MGTX) Stock Climbs in Pre-Hour Trading - Stocks Telegraph
MeiraGTx secures $200 million, forms joint venture for CNS drugs By Investing.com - Investing.com Australia
MeiraGTx Secures $200 Mln From Hologen For Phase 3 Dvpt. Of AAV-GAD, Establish Neuro-AI JV - Nasdaq
MeiraGTx Holdings PLC reports results for the quarter ended December 31Earnings Summary - TradingView
MeiraGTx Holdings Announces Joint Venture with Hologen - TipRanks
MeiraGTx secures $200 million, forms joint venture for CNS drugs - Investing.com
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - The Manila Times
MeiraGTx stock surges on Hologen AI deal By Investing.com - Investing.com South Africa
MeiraGTx stock surges on Hologen AI deal - Investing.com India
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process - The Manila Times
MeiraGTx and Hologen Limited Announce $200 Million Collaboration and Formation of Hologen Neuro AI Ltd Joint Venture for Parkinson's Disease Development - Nasdaq
Meiragtx Holdings Plc (MGTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):